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Abstract
Background: Crohn’s Disease (CD) is a chronic relapsing disorder characterized by granulomatous inflammation of the
gastrointestinal tract. Although its pathogenesis is complex, we have recently shown that CD patients have a systemic
defect in macrophage function, which results in the defective clearance of bacteria from inflammatory sites.
Methodology/Principal Findings: Here we have identified a number of additional macrophage defects in CD following
diacylglycerol (DAG) homolog phorbol-12-myristate-13-acetate (PMA) activation. We provide evidence for decreased DNA
fragmentation, reduced mitochondrial membrane depolarization, impaired reactive oxygen species production, diminished
cytochrome c release and increased IL-6 production compared to healthy subjects after PMA exposure. The observed
macrophage defects in CD were stimulus-specific, as normal responses were observed following p53 activation and
endoplasmic reticulum stress.
Conclusion: These findings add to a growing body of evidence highlighting disordered macrophage function in CD and,
given their pivotal role in orchestrating inflammatory responses, defective apoptosis could potentially contribute to the
pathogenesis of CD.
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Introduction
Crohn’s disease (CD) is a chronic relapsing inflammatory disease
of the gastrointestinal tract associated with considerable lifelong
morbidity[1]. It is characterized by granulomatous inflammation
that most frequently affects the terminal ileum and colon. The
incidence of CD has risen dramatically since the latter part of the
20
th century for reasons that remain poorly understood[2].
Despite tremendous advances in our understanding of the
immunology of the gastrointestinal tract, the pathogenesis of CD
remains elusive and highly contentious. Patient heterogeneity
supports the complex nature of this disease and is a major difficulty
in defining its cause. Various hypotheses concerning the
pathogenetic mechanisms have been proposed over the years[3].
Most implicate a dysregulated mucosal immune response to
intestinal luminal contents in those with a susceptible immuno-
logical background. The etiology of CD is almost certainly
multifactorial, with numerous genetic and environmental factors
that differ between individuals giving rise to a common syndrome.
We have previously shown a failure of acute inflammation in
CD that is systemic and operates at the level of the macro-
phage[4,5]. This defect results in diminished pro-inflammatory
cytokine release, reduced neutrophil recruitment and the persis-
tence of bacterial products within the tissue, which can potentially
drive chronic inflammation. Other groups have previously shown
abnormal apoptosis in both neutrophils and T-lymphocytes from
CD patients under a variety of conditions[6,7], and both anti-TNF
and 5-aminosalicylic acid (5-ASA) therapy have been shown to
induce apoptosis in leukocytes from CD patients[8–10]. These
observations lead us to investigate whether CD macrophages also
exhibit an apoptotic defect which may contribute to the immuno-
pathology of CD.
Apoptosis is a tightly-regulated mechanism in controlling tissue
homeostasis that can be initiated by a variety of signals and stress
factors; Its physiological and pathological importance is highlight-
ed by the fact that dysregulated apoptosis underlies many cancers
and malignancies[11]. Concurrently, it has been shown that CD
can predispose to an increased risk of developing colorectal
cancers[12]. Studies in mice showed that neutrophil and
macrophage apoptosis were characteristics of the resolving phase
of inflammation[13], suggesting an important role for apoptosis in
the resolution of inflammation, which is defective in many chronic
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extrinsic factors (through death domain-containing receptors) or
via intrinsic factors such as activation of tumor suppressor protein
p53, which is activated in response to DNA damage, UV radiation
and a range of chemotherapeutic drugs, and induces apoptosis-
regulating pathways involving the mitochondria[15,16]. Such
intrinsic factors also include reactive oxygen species (ROS), which
was shown to induce apoptosis in RAW264.7 macrophages and
are posited to function via the mitochondria[17,18]. Furthermore,
studies in murine hepatocytes have shown that ROS-induced
apoptosis required mitochondrial involvement in a protein kinase
C (PKC)-dependent manner[19]. PKCs are a group of kinases that
have been widely associated with apoptotic signaling[20]. Studies
have shown that the regulation of PKC activity is highly complex,
involving both a variety of phosphorylation events at different
amino acid residues and conformational changes/cleavages
conveying different states of (de)activation, depending on isoform,
cell type and stimulus[21–23]. In particular, novel isoforms PKCd
and PKCe have been implicated in regulating cell survival and
apoptosis[22], by interacting with a variety of proteins from the
apoptotic machinery, including mitochondria-associated genes
and caspases during apoptotic signaling processes[24,25].
In this study, we demonstrate that stimulation with the DAG-
homologue PMA[22] induces an abnormal apoptotic response,
reduced NADPH oxidase activation and elevated IL-6 secretion in
macrophage from CD patients. These findings add to a growing
body of evidence highlighting disordered macrophage function
during the acute inflammatory response in CD, providing further
insight about the pathogenesis of this chronic disorder.
Materials and Methods
Ethics Statement
These studies were approved by the Joint UCL/UCLH
Committee for the Ethics of Human Research (project number
04/0324). Written informed consent was obtained from all
volunteers.
Patients
Patients with endoscopically- and histologically-proven CD
were identified through the gastroenterology outpatient clinics at
University College London Hospitals (UCLH). All patients had
quiescent disease at time of venesection (Harvey-Bradshaw
Activity #3). Healthy controls were identified through the
Department of Medicine, University College London (UCL). No
subject was studied more than once in each of the different sets of
experiments.
Macrophage Isolation, Culture and Stimulation
Peripheral venous blood was collected from subjects into
syringes containing 5 U/ml heparin. Mononuclear cells were
isolated by differential centrifugation (2000 rpm, 30 min) over
Lymphoprep (Axis-Shield, Oslo, Norway) and macrophages
differentiated as previously described[5]. Adherent cells were
scraped on day 5 and re-plated at densities (10
6 cells/ml) in X-
Vivo-15 medium (Cambrex, MD, USA). Plated macrophages
were incubated overnight at 37uC, 5% CO2, and then stimulated
as appropriate. Stimuli used were PMA at 1 mg/ml, 1 mM RITA
(2,5-bis (5-hydroxymethyl-2-thienyl) furan, obtained from the
National Cancer Centre, Drug Therapeutic Program, Frederick
MD (NSC-652287)), 1 mM Thapsigargin (Sigma-Aldrich, UK),
and 2.5 mM N-Acetyl-L-cysteine (NAC) (Sigma-Aldrich, UK),
heat-killed E. coli (HkEc), prepared as previously described (4) at a
ratio of 2.5 HkEc/macrophage, 2 mg/ml Pam3CSK4 (P3C) (Alexis
Biochemicals, San Diego), 200 ng/ml LPS (Alexis). 1 mg/ml
Infliximab (RemicadeH) anti-TNF neutralizing antibody, human
recombinant TNF at 25 ng/ml (Calbiochem, CA, USA), and
human recombinant IL-6 at 10 ng/ml (R&D Systems, Abingdon,
UK). Inhibitors used were 1 mM PKC inhibitor Bisindolylmalei-
mide I (BIM), (Calbiochem) and 25 mM topoisomerase II inhibitor
etoposide phosphate (Sigma-Aldrich, UK).
MTT Cell Viability Assay
Cell viability was ascertained by MTT assay (Boehringer
Ingelheim, Berkshire, UK). Briefly, 20 ml of 2.5 ng/ml MTT
were added to each well and incubated for 18 hours (h) at 37uC,
5% CO2. Supernatants were discarded and 100 ml/well of lysis
solution (90% Isopropanol, 0.5% sodium dodecyl sulphate (SDS),
0.04 M NH4Cl, 9.5% H20) added to each well for 1 h at room
temperature. The absorbance was read at 570 nm using a
FLUOstar OMEGA microplate reader and software (BMG
LABTECH Ltd., Aylesbury, UK).
DNA Fragmentation Assay
Macrophages were stimulated and cells permeabilized in 0.1%
Triton X-100/PBS with 2 mM propidium iodide (PI) (Sigma-
Aldrich, UK) for 1 h in the dark. DNA fragmentation was assessed
by flow cytometry as previously described [26] using a FACSCa-
libur flow cytometer (BD Biosciences, NJ, USA), and analysis
performed using the Cellquest
TM software. The proportion of
DNA giving fluorescence below the G1-0 peak (gated as M1) was
used as a measure of apoptosis.
Beadlyte Cytokine Secretion Assays
The expression profile of a panel of cytokines in macrophage
supernatants was measured using the Beadlyte Bio-Plex
TM human
cytokine assay (Bio-Rad Laboratories, Hemel Hempstead, UK),
according to the manufacturer’s instructions. Our assay was
customized to detect and quantify IL-1ra, RANTES, IL-6, GM-
CSF and MCP-1.
ELISA
The concentrations of human IL-10 (PeproTech, Inc., NJ,
USA), IL6 (BD Biosciences) and IL-8 (PeproTech) were deter-
mined by ELISA according to the manufacturers’ instructions.
Cytochrome C concentrations in cell lysates were quantified using
the QuantikineH Human Cytochrome C Immunoassay (R&D
Systems) according to the manufacturer’s instructions. Absorbance
was read and analyzed at 450 nm on a FLUOstar OMEGA
microplate reader and software (BMG LABTECH Ltd., Ayles-
bury, UK).
TNF Bioassay
Release of bioactive TNF was measured using a cytotoxicity
bioassay (obtained from Prof. B. Beutler, The Scripps Institute,
CA, USA) as previously described[27]. Serially diluted rhTNF
(100–0 pg/ml) (Calbiochem) was used to determine the standard
curve for the assay.
AmplexH Red Reactive Oxygen Intermediate (ROI)
Release Assay
Release of H2O2 by PMA-stimulated HC and CD macrophages
was assessed by AmplexH Red fluorometric assay alongside a
standard curve. Cells were plated in a 96-well flat-bottomed plate
at a density of 10
5 cells/well. For inhibitor studies, cells were pre-
incubated with 1 mM inhibitor for 1 h. H2O2 production was
measured at 37uC in the presence of 4 mM AmplexH Red
Abnormal Apoptosis in Crohn’s
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(Sigma-Aldrich) and, where appropriate, 1 mg/ml PMA and
1 mM BIM in sterile PBS using the FLUOstar OMEGA
microplate reader (BMG LABTECH Ltd.). Excitation was set at
544 nm and emission was set at 590 nm, with measurements taken
at 30 sec intervals. Rate of H2O2 production per hour (nM/h) was
calculated over the first seven minutes (exponential phase) using
the FLUOstar OMEGA software (BMG LABTECH Ltd.).
Mitochondrial Membrane Potential Detection Assay
Loss of mitochondrial membrane potential in CD and HC
macrophages was measured by flow cytometry using the APO
LOGIX
TM JC-1 kit (Peninsula Laboratories, LLC, CA, USA)
according to the manufacturer’s instructions. Fluorescence was
measured using FACSCalibur flow cytometer (BD Biosciences, NJ,
USA), and analysis performed using the Cellquest
TM software.
Statistical Analysis
Data were analyzed using paired or unpaired t-test using the
GraphPad Prism 5 software.
Results
Abnormal PMA-Induced Cell Death Is Associated with
Macrophages from CD Patients
Abnormal apoptosis has been previously described in neutro-
phils and T lymphocytes isolated from CD patients[6,7,28–30].
We wanted to investigate the affects of numerous apoptotic stimuli
on macrophages as these cells have been shown to be defective in
patients with CD[5,4]. Cell survival was determined by measuring
the amount of DNA fragmentation before and after stimulation. In
contrast to a published report on T lymphocytes apoptosis levels,
baseline rate of DNA fragmentation was not significantly different
between CD and HC macrophages (Figure 1). Macrophages were
stimulated for 24 h with an panel of apoptosis-inducing agents:
RITA (p53-activating small molecule)[31,32], PMA, etoposide
(topoisomerase II inhibitor), thapsigargin (sacro/endoplasmic
reticulum (ER) Ca
2+ ATPase inhibitor, induces ER stress),
bacterial stimulation or TNF (Figure 1A). Increased DNA
fragmentation was observed after RITA, PMA and thapsigargin
stimulation in macrophages from HC and CD. Macrophages from
CD patients were more resistant to PMA-induced DNA
fragmentation (23.4610.7 %) compared to those from HC
(36.5611.6 %, p,0.0001) (Figure 1A and B). The addition of
TNF resulted in a moderate decrease in DNA fragmentation in
macrophages from CD subjects (1361.1 %) compared to
unstimulated cells (15.462% ,p ,0.05) and TNF treated HC
macrophages (2063% ,p ,0.05). Etoposide and bacteria exposure
had no effect on the level of DNA fragmentation compared to
unstimulated macrophages. Macrophages from CD patients
therefore undergo PMA-induced apoptosis, but the level of DNA
fragmentation is only 6464.4 % of that seen in HC. Decreased
rate of apoptosis in PMA-stimulated CD macrophages was
independent of disease phenotype (Figure S1), age (R
2=0.03)
and gender (p=0.1399) (Table S1). These data show that the
induction of apoptosis via p53 and ER stress pathways are
unaffected in macrophages from CD patients. In contrast,
abnormal macrophage apoptosis levels are evident after stimula-
tion with PMA and to a lesser extent TNF.
In order to determine if decreased PMA-induced DNA
fragmentation in macrophages from CD patients was the result
of alterations in cell viability, a MTT assay was performed
(Figure 1C). Macrophage survival 24 h after PMA stimulation was
significantly higher in CD (99.263.4 %) than in HC (70.964.9 %,
p,0.0001). These data show that macrophages from CD patients
are much more resistant to PMA-induced apoptosis resulting in
increased survival compared to HC. These results contrast with
our findings in patients with chronic granulomatous disease
(CGD)[33], who show normal PMA-induced macrophage apo-
ptosis despite frequently presenting with granulomatous enteroco-
litis indistinguishable from CD [34,35]. In addition, macrophages
from patients with ulcerative colitis demonstrate a decrease in
viability after PMA exposure (78.8 64.6 %, n=13) that was
equivalent to HC (p=0.29) and significantly different to CD
(p=0.018) (Figure S2). Defective macrophage viability after PMA
stimulation does not seem to be a consequence of general chronic
inflammation, but specific to patients with CD.
Loss of Mitochondrial Membrane Potential Is Impaired in
PMA-Stimulated CD Macrophages
Cell death via the apoptotic pathway results from a number of
key steps which include permeabilization of the mitochondrial
membrane and loss of membrane potential, cytochrome C release
and caspase 3 activation[36]. Ultimately these lead to DNA
fragmentation, membrane blebbing and apoptosis. Loss of
mitochondrial membrane potential in macrophages from CD
and HC following PMA stimulation for 24 h was measured
(Figure 2A and B). A significant loss of mitochondrial membrane
potential after PMA exposure was evident in both HC (p,0.001)
and CD (p,0.05) macrophages. The mean percentage of
macrophages demonstrating loss of mitochondrial membrane
potential was significantly lower in CD patients (10.362.2 %)
compared to HC (44.066.4, p,0.01) (Figure 2A and B).
Macrophages were incubated with RITA in order to investigate
p53 signaling which also results in loss of mitochondrial membrane
potential during the induction of apoptosis (Figure 2B)[31,15,32].
Stimulation with RITA induced a loss of mitochondrial membrane
potential in macrophages from both HC (p,0.01) and CD
(p,0.01), with no significant difference between the two groups
(p=0.3553). These findings further supporting the concept that
the intrinsic apoptotic pathway downsteam of p53 is able to
operate normally in macrophage from CD patients. Loss of
mitochondrial membrane potential results in the release of
cytochrome C[16], which was measured after stimulation.
Intracellular cytochrome C levels in macrophages from CD were
significantly lower than those in HC macrophages after PMA
stimulation (p,0.01, Figure 2C). Resistance to apoptosis in
mucosal T lymphocytes from CD patients has previously been
shown to correlate with decreased Bax expression[24]. We
therefore assessed Bax mRNA levels in HC and CD macrophages
following PMA stimulation by quantitative PCR. PMA exposure
resulted in the upregulation of Bax in HC macrophages
(Figure 2D). The upregulation of Bax was significantly lower in
macrophages from CD patients after PMA stimulation compared
to HC subjects (Figure 2D). These results are consistent with the
diminished apoptosis observed thus far, and provide further
evidence for a general dysregulation of PMA-induced responses in
macrophages from CD patients.
Defective PMA-Induced Reactive Oxygen Species (ROS)
Production in CD Macrophages
In addition to an apoptotic response, PMA stimulation also
induces the production of ROS in macrophages through the
activation of the NADPH oxidase system[37]. PMA-induced
ROS production, determined by H2O2 generation, in HC and
CD macrophages was assessed (Figure 3A). The rate of H2O2
production was significantly decreased in CD macrophages
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In order to assess whether there was a causal link between
reduced H2O2 production and decreased apoptosis in macro-
phages from CD patients in response to PMA, cells were treated
with the antioxidant N-acetyl-L-cysteine (NAC). Macrophages
from HC pre-treated with NAC reduced the amount of free
H2O2 after PMA-stimulation by 46.7 %, which was even greater
than the 17% observed with macrophages from CD patients
(Figure 3B). However, reduced H2O2 levels in the presence of
NAC had no effect on PMA-induced DNA fragmentation
(Figure 3C) or mitochondrial membrane potential (Figure 3D).
This indicates that the decreased ROS levels observed in
macrophages from CD patients are not associated with, and
consequently not responsible for the resistance to PMA induced
loss in cell viability.
Macrophages from CD patients demonstrate two distinct
abnormalities after PMA stimulation: increased resistance to
apoptosis and diminished NADPH oxidase activity. These results
are in line with our previous findings showing normal levels of
PMA-induced apoptosis in macrophages from CGD patients who
generate no ROS due to a complete absence in NADPH oxidase
activity[33].
Figure 1. Defective apoptosis in macrophages from CD subjects. A Macrophages from HC and CD patients were untreated or stimulated
with 1 mg/ml PMA (HC n=39, CD n=44), 1 mM RITA (HC n=10, CD n=7), 25 mM Etoposide (HC n=7, CD n=7), 1 mM Thapsigargin (HC n=9, CD
n=8) for 24 h, E. coli (HC n=10, CD n=12) or 25 ng/ml recombinant TNF. DNA fragmentation (events below the G1-0 peak) was assessed by flow
cytometry. Mean percentage 6 SEM of apoptosis for HC (black bars) and CD (open bars) are shown (
o significance between stimulated and untreated,
* between HC and CD). B Representative histograms for HC unstimulated (upper left panel), HC plus PMA 24 h (lower left), CD unstimulated (upper
right) and CD plus PMA 24 h (lower right). C Viability for CD and HC macrophages following stimulation with 1 mg/ml PMA for 24 h was assessed by
MTT assay. Data are presented as percent of untreated cells for HC (black squares, n=24) and CD (open circles, n=41) with group mean. Statistical
analysis: Paired or unpaired t-test. Symbols:p ,0.05 (* or
o), p,0.001 (*** or
ooo).
doi:10.1371/journal.pone.0007787.g001
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Patients in Response to PMA
Previously, we have reported a defective acute inflammatory
response to microbial challenge associated with macrophages from
CD patients[5,4]. We were therefore interested in determining the
effects of chronic activation and reduced apoptosis with the DAG
homolog-PMA on cytokine generation by macrophages from CD
subjects. Analyses of cytokines produced in response to PMA did
not reveal the same dramatic difference in cytokine release seen
with bacterial and toll-like receptor stimulation [5]: TNF, MCP-1,
IL-8, IL-1Ra, IL-10, GM-CSF and RANTES were released at
levels not significantly different from HC macrophages (Figure 4A).
Macrophages from CD patients produced significantly more IL-6
than HC at 24 h after PMA stimulation (Figure 4A, p,0.05).
Increased secretion of IL-6 by CD macrophages after PMA
stimulation is consistent with the elevated serum levels previously
reported for patients with active disease[38]. There is also a direct
correlation between IL-6 serum levels and disease severity[39]. IL-
6 has also been shown to produce anti-apoptotic effects via gp130
and the activation of the JAK/STAT3 pathway[40]. In order to
ascertain whether elevated IL-6 secretion exerted any effect on the
apoptotic response, HC and CD macrophages were stimulated
with recombinant IL-6 in the presence or absence of PMA.
Addition of IL-6 to HC and CD macrophages did not alter the
basal level of apoptosis seen in unstimulated cells (Figure 4B). As
shown previously, the macrophages from CD subjects were more
resistant to DNA fragmentation than HC after PMA activation.
The inclusion of IL-6 had no effect on the rate of DNA
fragmentation in either the HC or CD subjects with or without
PMA. STAT3 phosphorylation was also similar between the two
groups (data not shown). It therefore seems unlikely that the
elevation in IL-6 is responsible for the reduced apoptosis in
macrophages from CD patients.
PMA Induced Apoptosis and ROS Generation Signals
through a Bisindolylmaleimide Sensitive Pathway
PMA has been previously shown to activate a number of
intracellular signaling molecules which are sensitive to DAG
Figure 2. Mitochondrial membrane depolarization, cytochrome c and BAX expression are abnormal in CD macrophages after PMA
activation. Macrophages were stimulated with 1 mg/ml PMA for 24 h and the effects on mitochondrial membrane potential, cytochrome c and BAX
expression determined. A Representative histograms of macrophage population for HC unstimulated (upper left panel), HC PMA 24 h (lower left), CD
unstimulated (upper right) and CD PMA 24 h (lower right) are shown. Gated populations show cells with an intact mitochondrial membranes (M1)
and cells which have lost mitochondrial membrane integrity (M2). B Proportion of macrophages with mitochondrial membrane depolarization are
shown as mean percentage 6 SEM after either PMA (HC n=9, CD n=10) or RITA (HC n=5, CD n=5) stimulation. C Intracellular cytochrome C levels
in macrophages stimulated with 1 mg/ml PMA for 24 h were measured by ELISA. Cytochrome C production (ng/ml) at 24 h is shown for HC (n=4,
black bars) and CD (n=8, open bars). D Macrophages were stimulated with 1 mg/ml PMA for 4 h followed by total RNA isolation. Bax mRNA levels
were determined by qPCR and expressed as the change in expression compared to unstimulated cells. Statistical analysis: Paired or unpaired t-test.
Symbols:p ,0.05 (*), p,0.01 (**), p,0.001 (***).
doi:10.1371/journal.pone.0007787.g002
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classical and novel protein kinase C (PKC) family as well as a host
of other DAG responsive molecules[22]. The effects on apoptosis
and ROS generation in the presence of bisindolylmaleimide I
(BIM), a potent but none-selective inhibitor of PKC, were
assessed[41]. Pre-incubation with BIM significantly inhibits
PMA-induced DNA fragmentation (Figure 5A), mitochondrial
membrane depolarization (Figure 5B) and ROS generation
(Figure 5C) in macrophages from HC and from CD subjects.
The exact PMA sensitive molecules responsible for the abnormal-
ities are still unknown, but our findings suggest that the
abnormalities in macrophages from CD are downstream of a
BIM-sensitive PMA inducible pathway.
Discussion
This study identified several defects associated with macro-
phages from CD patients: 1) Macrophages show increased viability
and decreased apoptosis downstream of the DAG homolog PMA.
2) The impaired apoptotic response is PMA-specific, as activation
of apoptosis via p53 and ER stress are normal in CD
macrophages. 3) PMA-induced NADPH oxidase activity is also
impaired in CD macrophages. 4) PMA exposure also results in
elevated IL-6 release. In addition to these observations we have
recently described a major defect in the innate immune response
of CD patients in response to bacterial stimulation, which results in
impaired clearance as a consequence of defective cytokine
secretion from macrophages[5]. We therefore propose that
defective macrophage function plays a major role in the abnormal
acute inflammatory response and subsequent chronic granuloma-
tous inflammation in CD.
Studies investigating apoptosis in CD have thus far concentrat-
ed on lymphocytes and neutrophils[7,6,30,29,28], and this is the
first time that a defect in CD macrophage apoptosis has been
shown. Interestingly, aberrant apoptosis in T-lymphocytes was
observed in response to numerous apoptotic stimuli, including IL-
Figure 3. Decreased PMA-induced reactive oxygen species production in CD macrophages. NADPH oxidase activity was assessed by
measuring the generation of H2O2 by macrophages from HC and CD subjects after stimulation with 1 mg/ml PMA. A Production of H2O2 (nM/h) was
elevated after PMA stimulation in both HC (n=29) and CD (n=47) groups. Macrophages from CD patients demonstrated reduced H2O2 release than
HC. B H2O2 levels were determined after HC macrophages (n=4) pre-incubated with 2.5 mM N-Acetyl-L-cysteine (NAC) for 1 h followed by PMA
stimulation. The presence of NAC resulted in reduced H2O2 levels. C DNA fragmentation and D mitochondrial membrane potential were unaltered by
the presence of NAC. Statistical analysis: Paired or unpaired t-test. Symbols:p ,0.05 (*), p,0.01 (**), p,0.001 (***), HC (black bars), CD (white bars).
doi:10.1371/journal.pone.0007787.g003
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as well as lower spontaneous apoptosis in CD biopsy tissue
explants[30]. These data contrast with our findings on several
accounts. Firstly, baseline (spontaneous) macrophage apoptosis
was comparable in HC and CD subjects. Secondly, apoptotic
responses following p53 activation and ER stress induction were
normal, suggesting a more specific defect in macrophages
compared to T lymphocytes in CD. These cell-type-specific
differences are further highlighted by the fact that CD neutrophils
exhibit delayed apoptosis in suspension and accelerated apoptosis
following adhesion to fibronectin[30], and support our hypothesis
of CD as a multi-factorial syndrome that has multiple interacting
cellular and tissue components[5,42].
PMA acts through the activation of DAG responsive proteins
and targets a number of potential pathways in human macro-
phages. Protein kinase C (PKC) family members are especially
sensitive to PMA activation and have been implicated in the
induction of both apoptosis as well as NADPH oxidase
activity[43,44]. The conventional or classical PKCs (a, bI, bII
and c) and the novel PKCs (d, e, g and h) are all activated by the
additional binding of DAG or its homologue PMA[44]. Due to
this complexity we were unable to identify abnormal PKC activity
using isotype specific activation antibodies, but the inclusion of
BIM, a non-selective PKC inhibitor provided some evidence to
support their involvement. Furthermore, abnormal PKC activity
has previously been identified in CD patients during acute
inflammation[45]. Defective apoptosis and NADPH oxidase
activity may result from abnormal PKC activity but equally it
may depend on downstream events. The fact that apoptosis occurs
normally when p53 and ER stress are activated directly suggest
that the machinery required for programmed cell death functions
normally in CD macrophages. Further work is needed to identify
the specific PMA inducible defects in macrophages from CD
patients.
We have previously shown that macrophages from CGD
patients that completely lack NADPH oxidase activity apoptose
normally after PMA activation[33]. The inclusion of the ROS
sequester NAC resulted in decreased levels of H2O2 but had no
apparent effect on the apoptotic response in macrophages from
HC. These observations suggest that reduced NADPH oxidase
activity does not confer protection against apoptosis after PMA
stimulation in primary human macrophages.
Figure 4. Dysregulated PMA-induced IL-6 production in CD macrophages. A Cytokine secretion from HC (n=7) and CD (n=10)
macrophages following stimulation with 1 mg/ml PMA for six hours was assessed. IL-6 production was significantly elevated in macrophages from CD
patients compared to HC subjects. B Measuring the effect of elevated IL-6 (1 ng/ml) on DNA fragmentation in the presence or absence of PMA
stimulation. DNA fragmentation was unaltered by the inclusion of IL-6 in both HC (n=7) and CD (n=7) macrophages. Statistical analysis: Paired or
unpaired t-test. Symbols:p ,0.05 (*), p,0.01 (**), p,0.001 (***).
doi:10.1371/journal.pone.0007787.g004
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IL-6, a cytokine which has previously been associated with the
chronic phase of CD[38,46]. Macrophages are thought to be one
of the main cell types responsible for elevated intestinal IL-6
levels[47], and although our results show that IL-6 production
does not have an autocrine effect on macrophage apoptosis, it is
nonetheless possible that increased IL-6 levels in active CD
contributes to the pathogenesis. Current therapies for CD are
being developed that specifically target IL-6 and its receptor gp130
and the results from these studies will help to determine the precise
role IL-6 plays in the pathophysiology of CD[48]. Our previous
research has clearly shown that microbial stimulation resulted in
significantly reduced pro-inflammatory cytokine secretion, includ-
ing IL-6, in patients with CD[4,5]. This defect results in reduced
neutrophil recruitment and the retention of bacteria within the
tissue. It is plausible that chronic inflammation in CD is driven by
the residual bacteria/bowel content in combination with defective
macrophage apoptosis. This could result in the persistence of the
pro-inflammatory stimuli, prolonged cytokine secretion, a failure
in resolution, defective wound healing, granulomatous tissue
formation, angiogenesis, fibrosis and scar formation; all of which
are hallmarks of the chronic inflammatory phase in CD.
The precise mechanisms involved in acute inflammation and its
subsequent resolution remain poorly understood, although it has
become apparent that apoptosis plays an important role in the
resolution phase. Initial work identified neutrophil apoptosis as a
critical factor in switching off inflammation and inducing the
resolution phase[49]. More recently, a role for macrophage
apoptosis in the resolution phase of acute inflammation has been
described[13]. It now seems that the induction and subsequent
resolution of an acute inflammatory response require complex
coordinated phases with regards to cellular recruitment and
clearance of inflammatory cells. It is highly probable that defects
affecting these processes contribute to the onset of human
inflammatory diseases and specifically CD.
The importance of defective apoptosis in the immuno-pathology
of CD is further substantiated by evidence that several efficacious
CD therapies have the potential to induced apoptosis. Several
different TNF-antagonists show clinical efficacy in inflammatory
diseases[50]. These can broadly be divided into neutralizing
antibodies (infliximab and adalimumab) and recombinant recep-
tors (etanercept). Whilst both classes are equally clinically
efficacious in rheumatoid arthritis, the recombinant TNF
receptor/immunoglobulin G fusion protein etanercept is not
effective in CD[51]. Studies in peripheral and lamina propria T
lymphocytes have attributed this to the fact that, whilst both
classes therapeutics neutralize TNF in vitro, only the neutralizing
antibodies are capable of inducing apoptosis in these
cells[8,50,52]. It has thus been proposed that the beneficial effects
of anti-TNF therapies in active CD relate not to direct binding and
Figure 5. PMA induced apoptosis, NADPH oxidase activity and mitochondrial membrane depolarization are all inhibited by
Bisindolylmaleimide I. Macrophages from HC (n=5–10) and CD (n=5–10) were left untreated, or pre-incubated with 1 mM Bisindolylmaleimide I
(BIM) for 1 h followed by PMA stimulation. BIM significantly reduced A DNA fragmentation, B mitochondrial membrane depolarization and C H2O2
release in both HC and CD. Paired or unpaired t-test. Symbols:p ,0.05 (*), p,0.01 (**), p,0.001 (***), HC (black bars), CD (white bars).
doi:10.1371/journal.pone.0007787.g005
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forms and induction of leukocyte apoptosis[50]. Thiopurines and
methotrexate are immunosuppresants widely used in the treatment
of moderate to severe CD and other chronic inflammatory
conditions. Thiopurines have been shown to induce apoptosis via
induction of a mitochondrial pathway[53]. Methotrexate has been
shown to induce apoptosis as well as elevating ROS genera-
tion[54,55]. There is also evidence that 5-ASAs, another
commonly used group of drugs used in mild CD, may have the
ability to induced apoptosis in leukocytes[10,56,57]. Probiotics
have recently attracted much interest as a potential treatment for
CD. A recent study has shown that the administration of the
probiotic Lactobacillus casei resulted in an increase in the number of
intestinal lymphocytes undergoing apoptosis in active CD[58].
Collectively, these observations suggest that the clinical efficacy of
commonly used CD therapies might at least in part be due to
restoration of the apoptotic responses in macrophages and other
leukocytes. The association between therapeutic success in CD
and activation of apoptosis continue to increase and may be an
important consideration in future drug development for this
chronic inflammatory disease.
Supporting Information
Table S1 Patient demographics. All the CD patients used in this
study have been listed with gender, age, ethnicity, phenotype,
current treatment and smoking status if known. m = male, f =
female, TI = terminal ileal, MTX = methotrexate, * = data not
available.
Found at: doi:10.1371/journal.pone.0007787.s001 (0.01 MB
PDF)
Figure S1 Altered apoptotic response in CD macrophages is
independent of disease location. Data from CD macrophages
presented in Figure 1B are presented as percent of apoptotic cells
for each donor (HC n=39; CD n=44) sub-divided into disease
location: colonic disease (col) (n=15), ileocolonic disease (I/C)
(n=18) and terminal ileal disease (TI) (n=11). Statistical analysis:
Unpaired t-test. Symbols: p,0.001 (***), HC (black squares), col
CD (open triangles), I/C CD (grey triangles) and TI CD (black
triangles).
Found at: doi:10.1371/journal.pone.0007787.s002 (1.29 MB EPS)
Figure S2 Abnormal macrophage response to PMA stimulation
is specific for CD patients. Viability assay for macrophages from
CD, HC and ulcerative colitis subjects following stimulation with
PMA for 24 h. Data are presented as percent of untreated cells for
CD (blue, n=41), HC (red, n=24) and UC (black, n=13).
Statistical analysis: Unpaired t-test.
Found at: doi:10.1371/journal.pone.0007787.s003 (0.03 MB JPG)
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